Abstract
The study was to investigate the ability of the contrast pulse sequencing technology (CPS) and SonoVueTM (a new contrast agent) to delineate placental angioarchitecture and observe whether the time-intensity curves would reflect the feature of vascular perfusion in placental central arterial canal and intervillous space.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
